Monoclonal antibody
Identifiers |
---|
CAS Number | |
---|
ChemSpider | |
---|
UNII | |
---|
Chemical and physical data |
---|
Formula | C6748H10377N1773O2083S44 |
---|
Molar mass | 151081.21 g·mol−1 |
Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]
This drug was developed by Genentech/Roche.[citation needed]
References
- ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108" (PDF). WHO Drug Information. 26 (4).
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin, American Medical Association.